Attached files

file filename
EX-99.1 - EX-99.1 - NANOSPHERE INCd382461dex991.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): July 19, 2012

 

 

NANOSPHERE, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-33775   36-4339870

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

4088 Commercial Avenue, Northbrook, Illinois   60062
(Address of Principal Executive Offices)   (Zip Code)

(847) 400-9000

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 7.01 Regulation FD Disclosure

On July 19, 2012, Nanosphere, Inc. (the “Company”) (Nasdaq: NSPH) announced that it has priced its previously announced underwritten public offering of 10,500,000 shares of its common stock at a public offering price of $2.40 per share. In connection with the offering, the Company has also granted the underwriters a 30-day option to purchase up to an additional 1,575,000 shares of common stock to cover over-allotments, if any. Piper Jaffray & Co. is acting as the sole book-running manager and Roth Capital Partners is acting as co-manager for the offering.

Net proceeds from the sale of the shares of common stock after underwriting discounts and commissions and other offering expenses are expected to be approximately $23.4 million. If the underwriters exercise their over-allotment option in full, net proceeds from the offering will be approximately $26.9 million. The offering is subject to customary closing conditions and is expected to close on Tuesday, July 24, 2012.

The Company plans to use the net proceeds from the offering for general corporate purposes and working capital.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits.

 

Exhibit

No.

  

Description

99.1   

PressRelease of Nanosphere, Inc. dated July 19, 2012.

The information included in this Current Report on Form 8-K (including the exhibit hereto) is being furnished under Item 7.01, “Regulation FD Disclosure” and Item 9.01, “Financial Statements and Exhibits” of Form 8-K. As such, the information (including the exhibit) herein shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. This Current Report (including the exhibit hereto) will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NANOSPHERE, INC.
   
Dated: July 19, 2012   By:   /s/ Roger Moody
    Roger Moody
    Chief Financial Officer, Vice President of
Finance & Administration, Treasurer, Secretary

 

 

3


EXHIBIT INDEX

 

Exhibit
No.

  

Description

99.1    Press Release of Nanosphere, Inc. dated July 19, 2012.

 

4